Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“ConclusionThis explorative study suggests that NAC can have a hepatoprotective activity in patients receiving trabectedin allowing to maintain an adequate dose intensity and continuative administration in patients with impaired liver and renal function or developing treatment-induced hepatotoxicity.”
“Here we tested the hypothesis that pretreatment of rats with modulators of hepatic drug metabolism, β-naphthoflavone, phenobarbitone or N-acetylcysteine , protect rat livers against the effects of yondelis.”